The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. (Q51738782)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 December 2010

Language	Label	Description	Also known as
English	The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010.	scientific article published on 17 December 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

Carl-Heinz Wirsing von König

2

object named as

Carl-Heinz Wirsing von König

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

Stanley Plotkin

5

object named as

Stanley A Plotkin

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

4

object named as

Tina Tan

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

1

object named as

Nicole Guiso

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

language of work or name

0 references

publication date

17 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

29

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

6

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

1115-1121

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

The global pertussis initiative: process overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

New Pertussis Vaccination Strategies beyond Infancy: Recommendations by the Global Pertussis Initiative

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Pertussis of adults and infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Health burden of pertussis in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Transmission of Bordetella pertussis to young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Pertussis disease burden in the household: how to protect young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

The science and fiction of the "resurgence" of pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Pertussis: review of epidemiology, diagnosis, management and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Bordetella pertussis and pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Changing epidemiology and emerging risk groups for pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Pertussis immunisation in adolescents and adults--Bordetella pertussis epidemiology should guide vaccination recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

The epidemiology of pertussis in Germany: past and present

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Outbreak of pertussis in a fully immunized adolescent and adult population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Nosocomial infections and community clusters of pertussis in France, 2000-2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Epidemiology of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

[Are pertussis vaccination guidelines applied to adults and health care workers?]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

[Pertussis: incidence, symptoms and costs]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

A Placebo-Controlled Trial of a Pertussis-Toxoid Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Pertussis infection in the United States: role for vaccination of adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Nucleic Acid amplification tests for diagnosis of Bordetella infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Performance of Commercial Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

[Awareness and adherence to Pertussis vaccination guidelines by occupational medicine physicians in Paris healthcare institution]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Pertussis prevention and diagnosis practices for adolescents and adults among a national sample of French general practitioners

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.010

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.12.010

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21168525

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51738782&oldid=1775319408"